Innovotech Inc. Reports Results For Its Second Quarter And Half-Year Ended 30 June 2025 Biotech Investing
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer Biotech Investing
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors Biotech Investing
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team Biotech Investing
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors Biotech Investing
